TABUTEAU HERRIOT — SEC Form 4 filings

SEC reporting owner CIK 1219927. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-02-29 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Axsome Therapeutics, Inc. (AXSM)Chief Executive Officer, Director, 10% owner1320 legs · 673,000 sh · $110,582,64447

Form 4 filings — TABUTEAU HERRIOT

FiledFormIssuerReported transactionsSource
2026-08-074Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 45,004 @ $4.95 · Sale (S): 45,004 @ $212.01 · Option exercise (M): 4,660 @ $4.95 · Sale (S): 4,660 @ $213.95 · Option exercise (M): 45,004 (derivative) @ $0 · Option exercise (M): 4,660 (derivative) @ $0EDGAR
2026-07-014Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 49,666 @ $4.95 · Sale (S): 49,666 @ $240.25 · Option exercise (M): 49,666 (derivative) @ $0EDGAR
2026-06-094Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 49,670 @ $4.95 · Sale (S): 49,670 @ $241.01 · Option exercise (M): 49,670 (derivative) @ $0EDGAR
2026-04-234Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 24,081 (derivative) @ $0EDGAR
2026-02-274Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 54,623 (derivative) @ $0EDGAR
2026-02-024Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 32,410 @ $8.02 · Sale (S): 32,410 @ $185.60 · Option exercise (M): 32,410 (derivative) @ $0EDGAR
2026-01-074Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 78,703 @ $8.02 · Sale (S): 78,703 @ $171.28 · Option exercise (M): 29,450 @ $8.02 · Sale (S): 29,450 @ $172.33 · Option exercise (M): 31,261 @ $8.02 · Sale (S): 31,261 @ $170.38 · +3 moreEDGAR
2025-12-044Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 49,252 @ $8.02 · Sale (S): 49,252 @ $144.59 · Option exercise (M): 20,163 @ $8.02 · Sale (S): 20,163 @ $146.94 · Option exercise (M): 10,558 @ $8.02 · Sale (S): 10,558 @ $148.18 · +3 moreEDGAR
2025-11-054Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 91,705 @ $8.02 · Sale (S): 91,705 @ $132.34 · Option exercise (M): 50,459 @ $8.02 · Sale (S): 50,459 @ $133.79 · Option exercise (M): 21,775 @ $8.02 · Sale (S): 21,775 @ $134.49 · +3 moreEDGAR
2025-10-084Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 19,220 @ $8.02 · Sale (S): 19,220 @ $120.17 · Option exercise (M): 13,390 @ $8.02 · Sale (S): 13,390 @ $118.77 · Option exercise (M): 12,774 @ $8.02 · Sale (S): 12,774 @ $118.84 · +3 moreEDGAR
2025-09-164Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 27,907 @ $8.02 · Sale (S): 27,907 @ $118.96 · Option exercise (M): 15,254 @ $8.02 · Sale (S): 15,254 @ $117.37 · Option exercise (M): 19,719 @ $8.02 · Sale (S): 19,719 @ $114.19 · +3 moreEDGAR
2025-02-254Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 28,887 (derivative) @ $0 · Grant/award (A): 28,609 (derivative) @ $0 · Grant/award (A): 28,609 (derivative) @ $0EDGAR
2024-02-294Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 87,192 (derivative) @ $0 · Grant/award (A): 47,886 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1219927 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →